Claims for Patent: 7,816,080

Summary for Patent: 7,816,080

Title:	Identifying organisms by detecting intronic nucleic acid or encoded proteins
Abstract:	The present invention provides novel methods for characterizing organisms by identifying the presence, absence, size or sequence polymorphism of intronic regions. The method involves selecting intronic regions from nuclear or organellar gene sequences that are useful for differentiating between and among taxonomic groupings of organisms. Such intronic regions can be analyzed directly or after amplification in a primer extension reaction. The amplification product is then analyzed by, for example, size fractionation, nucleotide sequencing or (RFLP). Intronic regions that contain an open reading frame encoding all or a portion of a protein can be used to generate antibodies to detect the presence or absence of the protein, which indicates the presence or absence of the intronic region. Methods of detecting an organism in a sample by detecting the presence or absence of one or more intronic regions also are provided using nucleic acid based or immunological based approaches. Kits are provided for practicing the methods of the invention.
Inventor(s):	Honeycutt; Rhonda J. (Solana Beach, CA), McClelland; Michael (Encinitas, CA)
Assignee:	Clarity Biosciences, Inc. (Carlsbad, CA)
Application Number:	11/605,049
Patent Claims:	1. A method of characterizing a target organism suspected of being a member of a given taxonomic group comprising the steps of: (a) selecting at least one intronic region known to be found in some or all members of the taxonomic group, wherein the at least one intronic region comprises an organellar intron gene sequence or a nuclear Group I or Group II intron gene sequence, further wherein members of the taxonomic group are distinguishable by characteristics of the at least one intronic region; (b) analyzing the intronic region of the target organism to determine intronic region characteristics of the target organism, wherein the intronic region characteristics comprise the presence or absence of an intron gene sequence, an insertion site of the intron gene sequence, a length of an amplified nucleic acid product, and a sequence of the amplified nucleic acid product, wherein analyzing the intronic region comprises a method selected from one or more of the group consisting of (i) hybridizing an exogenous nucleic acid sequence to the intronic region, mRNA or the amplified nucleic acid product, (ii) cleaving the intronic region or amplified nucleic acid product with a cleaving agent, (iii) sequencing a portion of the intronic region RNA or DNA or the amplified nucleic acid product with a nucleic acid sequencer, (iv) electrophoresing a portion of the intronic region or amplified nucleic acid product through a solution, and (v) detecting intronic regions encoding a protein by an immunoassay; and (c) comparing the intronic region characteristics of the target organism to the characteristics of the members of the taxonomic group to characterize the target organism. 2. A method of characterizing a target organism suspected of being a member of a given taxonomic group comprising the steps of: (a) selecting at least one intronic region known to be found in some or all members of the taxonomic group, wherein the at least one intronic region comprises an organellar intron gene sequence or a nuclear Group I or Group II intron gene sequence, further wherein members of the taxonomic group are distinguishable by characteristics of the at least one intronic region; (b) analyzing the intronic region of the target organism to determine intronic region characteristics of the target organism, wherein the intronic region characteristics comprise the presence or absence of an intron gene sequence, an insertion site of the intron gene sequence, a length of an amplified nucleic acid product, and a sequence of the amplified nucleic acid product, wherein analyzing the intronic region comprises: (i) choosing a pair of intronic region-specific primers suitable for amplifying the intronic region; (ii) performing a primer extension reaction to generate-primer amplified products; and (iii) analyzing the amplified products; and (c) comparing the intronic region characteristics of the target organism to the characteristics of the members of the taxonomic group to characterize the target organism. 3. The method of claim 2, further comprising the step of detennining the length of the intronic region. 4. The method of claim 2, further comprising the step of analyzing restriction fragment length polymorphism of the intronic region. 5. The method of claim 2, further comprising hybridizing the amplified product with specific nucleic acid probes. 6. The method of claim 2, wherein the intronic region-specific primers flank more than one intron insertion site. 7. The method of claim 2, wherein the intronic region-specific primers flank a single intron insertion site. 8. The method of claim 2, wherein at least one of the intronic region-specific primers is complementary to a sequence of nucleotides in an exon. 9. The method of claim 2, wherein the amplification product is analyzed by hybridizing it to a nucleic acid probe. 10. The method of claim 1, wherein the organism is a eukaryote. 11. The method of claim 10, wherein the eukaryote is a fungi. 12. The method of claim 11, wherein the fungi is of the genus Candida or Aspergillus. 13. The method of claim 1, wherein the target organism is found in a sample from an animal or a plant source. 14. The method of claim 1, wherein the target organism is found in a sample from a human source. 15. The method of claim 1, wherein the intronic region further comprises all or a portion of an open reading frame that encodes a protein. 16. The method of claim 1, wherein the at least one intronic region comprises the organellar gene sequence. 17. A method of characterizing a target organism suspected of being a member of a given taxonomic group, comprising the steps of: (a) determining intronic region characteristics from an organellar intron gene sequence of a target organism, wherein the intronic region characteristics comprise the presence or absence of an intron gene sequence, an insertion site of the intron gene sequence, a length of an amplified nucleic acid product, and a sequence of the amplified nucleic acid product, wherein determining intronic region characteristics comprises a method selected from one or more of the group consisting of (i) hybridizing an exogenous nucleic acid sequence to the intronic region, mRNA or the amplified nucleic acid product, (ii) cleaving the intronic region or amplified nucleic acid product with a cleaving agent, (iii) sequencing a portion of the intronic region RNA or DNA or the amplified nucleic acid product with a nucleic acid sequencer, (iv) electrophoresing a portion of the intronic region or amplified nucleic acid product through a solution, and (v) detecting intronic regions encoding a protein by an immunoassay; (b) comparing the intronic region characteristics to a panel of known intronic region characteristics that characterize members within the taxonomic group; and (c) characterizing the target organism as a member of the taxonomic group according to the comparison.

Details for Patent 7,816,080

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-03-29